For the Inventor, By the Inventor

Enter assignee name

Maisons Alfort, France

Laboratoire L. Lafon

USPTO Granted Patents = 69

Forward Citations = 829

Loading Chart...

Loading Chart...

30 inventors (with patents filed for the assignee):

Louis L Lafon (47 out of 57 patents)

Philippe Laurent (8 out of 14 patents)

Marguerite Henry (4 out of 4 patents)

4. Francis Darro (3 out of 5 patents)

5. Robert Kiss (3 out of 8 patents)

6. Armand Frydman (3 out of 4 patents)

7. Thierry Giboulot (3 out of 3 patents)

8. Christophe Yue (3 out of 3 patents)

9. Brigitte Lesur (3 out of 3 patents)

10. Gérald Guillaumet (2 out of 11 patents)

11. Benoît Joseph (2 out of 2 patents)

12. Janine Cossy (1 out of 4 patents)

13. Thanh-Tam Nguyen (1 out of 2 patents)

14. Jérôme Besse (1 out of 1 patent)

15. Tam Nguyen (1 out of 1 patent)

Core Competencies:

Pharmaceutical Composition

Quinoline Derivatives

Topoisomerase Inhibitors

Transdermal Administration

Piperazinone Derivatives

Dihydropyridine Derivatives

Neuroprotective Agents

Antidepressant Compounds

Sedative Agents

Therapeutic Peptides

Antithrombotic Agents

Galenic Formulations

69 patents: Sort by Forward Citations

1. 7033606 - Pharmaceutical composition intended in particular for the prevention and the treatment of radiomucositis and chemomucositis (2006-04-25),

2. 6809096 - Phenanthroline-7-one derivatives and their therapeutic uses (2004-10-26),

3. 6645983 - Pharmaceutical compositions comprising 4-quinolones for treating cancers (2003-11-11),

4. 6593342 - Pharmaceutical compositions comprising 2-quinolones (2003-07-15),

5. 6562788 - Topoisomerase II inhibitor (2003-05-13),

6. 6538039 - Pharmaceutical dosage form for transdermal administration (2003-03-25),

7. 6515127 - Method for preparing quinoline-5,8-diones (2003-02-04),

8. 6344456 - Piperazinone derivatives and their uses (2002-02-05),

9. 6335337 - Substituted piperazinones and their therapeutic uses (2002-01-01),

10. 6333338 - Bispiperidines as antithrombotic agents (2001-12-25),

11. 6268397 - Use of (&agr;-aminomethyl-3,4-dichlorobenzyl) thioacetamide derivatives for inhibiting dopamine reuptake and new compounds for this use (2001-07-31),

12. 6166035 - 1,4-dihydropyridine derivatives and their use in therapy (2000-12-26),

13. 5843347 - Extrusion and freeze-drying method for preparing particles containing an (1998-12-01),

14. 5795915 - Use of (x-aminomethyl-3,4-dichlorobenzyl) thioacetamide derivatives for (1998-08-18),

15. 5719168 - Acetamide derivatives and their use as feeding behaviour modifiers (1998-02-17),

Laboratoire L. Lafon is a pharmaceutical company specializing in the research, development, and production of innovative medical solutions. With a focus on delivering high-quality and safe medications, the company constantly strives for excellence in the healthcare industry. By leveraging cutting-edge technology and conducting extensive research, Laboratoire L. Lafon aims to address unmet medical needs and improve patient outcomes. Visit their website for more information about their products, research, and commitment to innovation.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

69 Patents

#1 in Maisons Alfort

#360 in France

#10,483 in the World

Maisons Alfort, France

Laboratoire L. Lafon

Forward Citations = 829

30 inventors:

Louis L Lafon (47 out of 57 patents)

Philippe Laurent (8 out of 14 patents)

Marguerite Henry (4 out of 4 patents)

4. Francis Darro (3 out of 5 patents)

5. Robert Kiss (3 out of 8 patents)

Please report any incorrect information to support@idiyas.com

Loading…